SCHEDULE: SilverArc Capital Management Reports Zero Ownership

SilverArc Capital Management, LLC and Devesh Gandhi report zero beneficial ownership of Kalvista Pharmaceuticals, Inc. Class A Common Stock as of June 30, 2026.

Summary

• SilverArc Capital Management, LLC and Devesh Gandhi have filed a Schedule 13G.
• The filing indicates that as of June 30, 2026, they beneficially own 0 shares of Kalvista Pharmaceuticals, Inc. Class A Common Stock.
• This represents 0% of the class of securities.
• Both reporting persons have 0 sole and shared voting power and 0 sole and shared dispositive power.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of influencing control of the issuer.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a neutral filing, primarily indicating a lack of significant beneficial ownership rather than a change in investment strategy or company performance.

Negatives

• Reporting persons hold no shares, indicating no current investment or influence.

Future Outlook

No forward-looking statements or guidance are provided in this filing.

Management Comments

• "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under 240.14a-11."

Industry Context

StockSavvy.ai notes that Schedule 13G filings are typically made by institutional investors who acquire beneficial ownership of more than 5% of a class of a company's registered equity securities. A filing reporting 0% ownership suggests either a recent divestment, a correction of a previous filing, or that the entity is not currently a significant shareholder.

Stakeholder Impact

• Shareholders: No immediate impact expected as the filing indicates no change in significant beneficial ownership.

Key Dates

Keywords

Schedule 13G, Beneficial Ownership, Kalvista Pharmaceuticals, SilverArc Capital Management, Devesh Gandhi, Common Stock